Opto Circuits India Ltd's wholly owned subsidiary, Eurocor GmBH has received the CE mark approval of its Taxcor paclitaxel-eluting coronary stent system. This regulatory certification allows Eurocor to begin marketing the drug eluting stents in 25 countries of the European Union as well as in Middle East Latin America and Asia.
According to the company release, this product is based on the mega flexibility platform technology which ensures lowest stent friction to the arterial wall in particular after drug elution is done.